title: Combined BRAF and MEK inhibition in BRAF(V600E) mutant melanoma: a synergistic and potentially safe combination partner with immunotherapy.
authors.affiliation: Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
authors.forename: Patrick A
authors.initials: PA
authors.lastname: Ott